Haruhiko Kuno

452 total citations
16 papers, 357 citations indexed

About

Haruhiko Kuno is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haruhiko Kuno has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Haruhiko Kuno's work include Peptidase Inhibition and Analysis (4 papers), Receptor Mechanisms and Signaling (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Haruhiko Kuno is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Receptor Mechanisms and Signaling (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Haruhiko Kuno collaborates with scholars based in Japan. Haruhiko Kuno's co-authors include Motonobu Satoh, Jun Terauchi, Masao Takeuchi, Takashi Santou, Masakuni Kori, Kenjiro Sato, Osamu Uchikawa, Naoyuki Kanzaki, Hiroshi Nara and Hideyuki Oki and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Haruhiko Kuno

15 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruhiko Kuno Japan 11 165 114 104 59 51 16 357
Jos de Man Netherlands 13 262 1.6× 122 1.1× 50 0.5× 10 0.2× 50 1.0× 22 497
M. Anthony Leesnitzer United States 10 288 1.7× 179 1.6× 122 1.2× 31 0.5× 45 0.9× 11 536
Zhaoxi Ding China 6 385 2.3× 369 3.2× 65 0.6× 22 0.4× 16 0.3× 13 689
Ming Guo China 8 353 2.1× 134 1.2× 44 0.4× 17 0.3× 132 2.6× 14 540
Barri Wautlet United States 9 191 1.2× 119 1.0× 51 0.5× 32 0.5× 152 3.0× 11 414
Ellin‐Kristina Hillert Sweden 8 279 1.7× 106 0.9× 20 0.2× 15 0.3× 23 0.5× 8 418
C-T Yeh Taiwan 7 277 1.7× 75 0.7× 68 0.7× 10 0.2× 26 0.5× 7 389
Christine R. Hoffman United States 10 344 2.1× 155 1.4× 68 0.7× 32 0.5× 54 1.1× 12 554
Amriti R. Lulla United States 11 277 1.7× 135 1.2× 97 0.9× 14 0.2× 12 0.2× 24 434
Zhanzhan Feng China 14 273 1.7× 102 0.9× 35 0.3× 9 0.2× 61 1.2× 19 395

Countries citing papers authored by Haruhiko Kuno

Since Specialization
Citations

This map shows the geographic impact of Haruhiko Kuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Kuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Kuno more than expected).

Fields of papers citing papers by Haruhiko Kuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Kuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Kuno. The network helps show where Haruhiko Kuno may publish in the future.

Co-authorship network of co-authors of Haruhiko Kuno

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Kuno. A scholar is included among the top collaborators of Haruhiko Kuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Kuno. Haruhiko Kuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Suzuki, Atsushi, Akiyoshi Kunugi, Noriko Suzuki, et al.. (2021). Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement. Scientific Reports. 11(1). 14532–14532. 11 indexed citations
3.
Yoshikawa, Kyoko, et al.. (2018). Identification of a novel series of potent and selective CCR6 inhibitors as biological probes. Bioorganic & Medicinal Chemistry Letters. 28(18). 3067–3072. 13 indexed citations
4.
Kunugi, Akiyoshi, et al.. (2018). HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production. Journal of Pharmacology and Experimental Therapeutics. 364(3). 377–389. 23 indexed citations
5.
Kunugi, Akiyoshi, Maiko Tanaka, Atsushi Suzuki, et al.. (2018). TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window. Neuropsychopharmacology. 44(5). 961–970. 21 indexed citations
6.
Furukawa, Hideki, et al.. (2017). Identification of 3,4-dihydro-2 H -thiochromene 1,1-dioxide derivatives with a phenoxyethylamine group as highly potent and selective α 1D adrenoceptor antagonists. European Journal of Medicinal Chemistry. 139. 114–127. 5 indexed citations
7.
Nara, Hiroshi, Kenjiro Sato, Hideyuki Oki, et al.. (2016). Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors. Bioorganic & Medicinal Chemistry. 24(23). 6149–6165. 27 indexed citations
9.
Nara, Hiroshi, Kenjiro Sato, Hideyuki Mototani, et al.. (2016). Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach. Journal of Medicinal Chemistry. 60(2). 608–626. 42 indexed citations
10.
Nara, Hiroshi, Kenjiro Sato, Hideyuki Mototani, et al.. (2014). Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site. Bioorganic & Medicinal Chemistry. 22(19). 5487–5505. 37 indexed citations
11.
Nara, Hiroshi, Kenjiro Sato, Hideyuki Mototani, et al.. (2014). Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach. Journal of Medicinal Chemistry. 57(21). 8886–8902. 49 indexed citations
12.
Kuno, Haruhiko, et al.. (1999). A simple and rapid reverse transcriptase assay for the detection of retroviruses in cell cultures. Cytotechnology. 29(3). 221–227. 1 indexed citations
13.
Satoh, Motonobu, et al.. (1998). Establishment of an epidermal growth factor-dependent, multipotent neural precursor cell line. In Vitro Cellular & Developmental Biology - Animal. 34(7). 585–592. 20 indexed citations
14.
Satoh, Motonobu, et al.. (1998). Platelet‐like particle formation in the human megakaryoblastic leukaemia cell lines, MEG‐01 and MEG‐01s. British Journal of Haematology. 100(2). 436–444. 56 indexed citations
16.
Satoh, Motonobu, et al.. (1993). Cytokines affecting survival and differentiation of an astrocyte progenitor cell line. Developmental Brain Research. 76(1). 147–150. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026